MED Medifast Inc
Price (delayed)
$13.14
Market cap
$143.72M
P/E Ratio
69.16
Dividend/share
N/A
EPS
$0.19
Enterprise value
$68.92M
Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a
Highlights
The company's quick ratio has surged by 55% YoY and by 8% QoQ
Medifast's debt has decreased by 27% YoY and by 9% from the previous quarter
The price to earnings (P/E) is 103% more than the last 4 quarters average of 34.0
The EPS has dropped by 98% year-on-year and by 71% since the previous quarter
Key stats
What are the main financial stats of MED
Market
Valuations
Earnings
Shares outstanding
10.94M
Market cap
$143.72M
Enterprise value
$68.92M
Price to earnings (P/E)
69.16
Price to book (P/B)
0.68
Price to sales (P/S)
0.24
EV/EBIT
N/A
EV/EBITDA
4.26
EV/Sales
0.11
Revenue
$602.46M
Gross profit
$444.62M
Operating income
$2.88M
Net income
$2.09M
EBIT
-$1.02M
EBITDA
$16.18M
Free cash flow
$17.02M
Per share
Balance sheet
Liquidity
EPS
$0.19
EPS diluted
$0.19
Free cash flow per share
$1.56
Book value per share
$19.21
Revenue per share
$55.12
TBVPS
$26
Total assets
$284.21M
Total liabilities
$74.1M
Debt
$16.13M
Equity
$210.11M
Working capital
$150.24M
Debt to equity
0.08
Current ratio
3.34
Quick ratio
2.53
Net debt/EBITDA
-4.62
Margins
Efficiency
Dividend
EBITDA margin
2.7%
Gross margin
73.8%
Net margin
0.3%
Operating margin
0.5%
Return on assets
0.7%
Return on equity
1%
Return on invested capital
-0.7%
Return on capital employed
-0.5%
Return on sales
-0.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MED stock price
How has the Medifast stock price performed over time
Intraday
-2.52%
1 week
-5.19%
1 month
-8.5%
1 year
-64.97%
YTD
-25.43%
QTD
-2.52%
Financial performance
How have Medifast's revenue and profit performed over time
Revenue
$602.46M
Gross profit
$444.62M
Operating income
$2.88M
Net income
$2.09M
Gross margin
73.8%
Net margin
0.3%
The operating income has shrunk by 98% YoY and by 73% QoQ
MED's net income has shrunk by 98% YoY and by 71% QoQ
Medifast's net margin has plunged by 97% YoY and by 73% from the previous quarter
Medifast's operating margin has shrunk by 96% YoY and by 69% QoQ
Growth
What is Medifast's growth rate over time
Valuation
What is Medifast stock price valuation
P/E
69.16
P/B
0.68
P/S
0.24
EV/EBIT
N/A
EV/EBITDA
4.26
EV/Sales
0.11
The price to earnings (P/E) is 103% more than the last 4 quarters average of 34.0
The EPS has dropped by 98% year-on-year and by 71% since the previous quarter
MED's P/B is 92% below its 5-year quarterly average of 8.6 and 48% below its last 4 quarters average of 1.3
The equity has grown by 4.3% YoY
The P/S is 80% lower than the 5-year quarterly average of 1.2 and 40% lower than the last 4 quarters average of 0.4
MED's revenue is down by 44% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Medifast business performance
The return on sales has dropped by 115% since the previous quarter and by 102% year-on-year
The return on invested capital has dropped by 111% since the previous quarter and by 101% year-on-year
MED's ROE has shrunk by 98% YoY and by 72% QoQ
The ROA has plunged by 98% YoY and by 71% from the previous quarter
Dividends
What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Medifast financials performed over time
The company's quick ratio has surged by 55% YoY and by 8% QoQ
MED's current ratio is up by 37% year-on-year and by 7% since the previous quarter
Medifast's debt is 92% less than its equity
Medifast's debt has decreased by 27% YoY and by 9% from the previous quarter
Medifast's debt to equity has decreased by 27% YoY and by 11% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.